Skip to content

8-KAccepted Mar 6, 4:05 PM ET

Ambrx Biopharma, Inc. 8-K

Ambrx Biopharma, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

4:05 PM

Mar 6, 2024

Filed

Mar 6, 2024

Documents

13

Size

175.1 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.